Section Arrow
ONCO.NASDAQ
- Onconetix Inc.
Quotes are at least 15-min delayed:2026/06/02 08:22 EDT
Pre Market
Last
 1.15
+0.01 (+0.88%)
Bid
1.14
Ask
1.15
High 1.17 
Low 1.11 
Volume 47.24K 
Regular Hours (Closed)
Last
 1.14
-0.06 (-5.00%)
Day High 
1.19 
Prev. Close
1.2 
1-M High
6.945 
Volume 
432.75K 
Bid
1.14
Ask
1.15
Day Low
1.122 
Open
1.17 
1-M Low
0.911 
Market Cap 
1.38M 
Currency 美元 
P/E
%Yield -- 
10-SMA 1.63 
20-SMA 3.13 
50-SMA 9.77 
52-W High 382.5 
52-W Low 0.911 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
1,377.40/-1.18
Enterprise Value
1.40M
Balance Sheet
Book Value Per Share
10.25
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
815.37K
Operating Revenue Per Share
--
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
AIMAIM ImmunoTech Inc.0.8986+0.4908+120.35%-- 
Pre Market 0.8302 -0.0684 -7.61%
GNTAGenenta Science SpA1.65+0.62+60.19%-- 
Pre Market 1.52 -0.13 -7.88%
OTLKOutlook Therapeutics0.843+0.113+15.48%-- 
Pre Market 0.8978 +0.0548 +6.50%
ADTXAditxt Inc.0.113-0.0042-3.58%-- 
Pre Market 0.0943 -0.0187 -16.55%
RXRXRecursion Pharmaceuticals3.79+0.2+5.57%-- 
Pre Market 3.749 -0.041 -1.08%
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Onconetix Inc is a commercial-stage biotechnology company focused on the research, development, and commercialization of solutions for men's health and oncology. The company owns Proclarix, an in vitro diagnostic test for prostate cancer, approved for sale in the European Union. Additionally, it is focused on marketing Proclarix in the U.S. as a lab-developed product. Onconetix operates in one segment: commercial. Geographically, the company generates maximum revenue from Switzerland and the rest from the United Kingdom.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.